# A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers

> **NCT01947920** · PHASE1 · COMPLETED · sponsor: **Janssen Scientific Affairs, LLC** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tramadol HCl, 50 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01947920
- **Lead sponsor:** Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-12-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01947920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01947920, "A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01947920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*